skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,088  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: Bmc Cancer remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Hematologic markers of distant metastases and poor prognosis in gynecological cancers
Material Type:
Article
Add to My Research

Hematologic markers of distant metastases and poor prognosis in gynecological cancers

BMC cancer, 2019-02, Vol.19 (1), p.141-8, Article 141 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5326-9 ;PMID: 30755184

Full text available

2
GLUT-1 as a predictor of worse prognosis in pancreatic adenocarcinoma: immunohistochemistry study showing the correlation between expression and survival
Material Type:
Article
Add to My Research

GLUT-1 as a predictor of worse prognosis in pancreatic adenocarcinoma: immunohistochemistry study showing the correlation between expression and survival

BMC cancer, 2020-09, Vol.20 (1), p.909-909, Article 909 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07409-9 ;PMID: 32967636

Full text available

3
Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?
Material Type:
Article
Add to My Research

Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?

BMC cancer, 2019-11, Vol.19 (1), p.1086-1086, Article 1086 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-6325-6 ;PMID: 31718601

Full text available

4
Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma
Material Type:
Article
Add to My Research

Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma

BMC cancer, 2015-07, Vol.15 (1), p.558-558, Article 558 [Peer Reviewed Journal]

COPYRIGHT 2015 BioMed Central Ltd. ;COPYRIGHT 2015 BioMed Central Ltd. ;Copyright BioMed Central 2015 ;Adeberg et al. 2015 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-015-1545-x ;PMID: 26223282

Full text available

5
LINC00511 as a prognostic biomarker for human cancers: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

LINC00511 as a prognostic biomarker for human cancers: a systematic review and meta-analysis

BMC cancer, 2020-07, Vol.20 (1), p.682-682, Article 682 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07188-3 ;PMID: 32698787

Full text available

6
The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study
Material Type:
Article
Add to My Research

The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study

BMC cancer, 2021-10, Vol.21 (1), p.1115-1115, Article 1115 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08832-2 ;PMID: 34663236

Full text available

7
Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2)
Material Type:
Article
Add to My Research

Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2)

BMC cancer, 2021-06, Vol.21 (1), p.1-667, Article 667 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08416-0 ;PMID: 34088300

Full text available

8
Determination of drug-related problems in the hematology service: a prospective interventional study
Material Type:
Article
Add to My Research

Determination of drug-related problems in the hematology service: a prospective interventional study

BMC cancer, 2024-05, Vol.24 (1), p.552-552 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12291-w ;PMID: 38698336

Full text available

9
Multizonal anogenital neoplasia in women: a cohort analysis
Material Type:
Article
Add to My Research

Multizonal anogenital neoplasia in women: a cohort analysis

BMC cancer, 2021-03, Vol.21 (1), p.232-232, Article 232 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-07949-8 ;PMID: 33676451

Full text available

10
Randomized double-blind clinical trial comparing safety and efficacy of the biosimilar BCD-022 with reference trastuzumab
Material Type:
Article
Add to My Research

Randomized double-blind clinical trial comparing safety and efficacy of the biosimilar BCD-022 with reference trastuzumab

BMC cancer, 2020-08, Vol.20 (1), p.783-10, Article 783 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07247-9 ;PMID: 32819305

Full text available

11
Correlation between initial tumour volume and treatment duration on Dabrafenib: observation study of subjects with BRAF mutant melanoma on the BRF112680 trial
Material Type:
Article
Add to My Research

Correlation between initial tumour volume and treatment duration on Dabrafenib: observation study of subjects with BRAF mutant melanoma on the BRF112680 trial

BMC cancer, 2020-04, Vol.20 (1), p.342-8, Article 342 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-06848-8 ;PMID: 32321474

Full text available

12
Cell-in-cell phenomenon associates with aggressive characteristics and cancer-related mortality in early oral tongue cancer
Material Type:
Article
Add to My Research

Cell-in-cell phenomenon associates with aggressive characteristics and cancer-related mortality in early oral tongue cancer

BMC cancer, 2020-09, Vol.20 (1), p.843-843, Article 843 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07342-x ;PMID: 32883229

Full text available

13
Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015–2016
Material Type:
Article
Add to My Research

Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015–2016

BMC cancer, 2021-08, Vol.21 (1), p.1-897, Article 897 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08623-9 ;PMID: 34362343

Full text available

14
Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
Material Type:
Article
Add to My Research

Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients

BMC cancer, 2019-04, Vol.19 (1), p.316-316, Article 316 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5529-0 ;PMID: 30953461

Full text available

15
Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer
Material Type:
Article
Add to My Research

Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer

BMC cancer, 2012-07, Vol.12 (1), p.298-298, Article 298 [Peer Reviewed Journal]

COPYRIGHT 2012 BioMed Central Ltd. ;COPYRIGHT 2012 BioMed Central Ltd. ;2012 Arias-Pulido et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2012 Arias-Pulido et al.; licensee BioMed Central Ltd. 2012 Arias-Pulido et al.; licensee BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/1471-2407-12-298 ;PMID: 22813402

Full text available

16
Interleukin-24-mediated antitumor effects against human glioblastoma via upregulation of P38 MAPK and endogenous TRAIL-induced apoptosis and LC3-II activation-dependent autophagy
Material Type:
Article
Add to My Research

Interleukin-24-mediated antitumor effects against human glioblastoma via upregulation of P38 MAPK and endogenous TRAIL-induced apoptosis and LC3-II activation-dependent autophagy

BMC cancer, 2023-06, Vol.23 (1), p.519-519, Article 519 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11021-y ;PMID: 37280571

Full text available

17
Changes after cancer diagnosis and return to work: experience of Korean cancer patients
Material Type:
Article
Add to My Research

Changes after cancer diagnosis and return to work: experience of Korean cancer patients

BMC cancer, 2021-01, Vol.21 (1), p.86-11, Article 86 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-07812-w ;PMID: 33478405

Full text available

18
Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients
Material Type:
Article
Add to My Research

Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients

BMC cancer, 2021-02, Vol.21 (1), p.146-7, Article 146 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-07868-8 ;PMID: 33563241

Full text available

19
Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP)
Material Type:
Article
Add to My Research

Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP)

BMC cancer, 2021-11, Vol.21 (1), p.1236-1236, Article 1236 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08885-3 ;PMID: 34794411

Full text available

20
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019
Material Type:
Article
Add to My Research

Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019

BMC cancer, 2021-06, Vol.21 (1), p.1-730, Article 730 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08451-x ;PMID: 34172037

Full text available

Results 1 - 20 of 1,088  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait